{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181797.3:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_181797.3",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S (LRRK2 mutation associated with Parkinson's disease)"
        }
      ]
    },
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_001108.3:c.527A>C",
          "cDNA Change": {
            "transcript": "NM_001108.3",
            "ref": "A",
            "alt": "C",
            "position": "527"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "Q",
            "position": "176"
          },
          "Description in input context": "p.L176Q (PARK2 mutation linked to Parkinson's disease)"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.2:c.311G>A",
          "cDNA Change": {
            "transcript": "NM_000345.2",
            "ref": "G",
            "alt": "A",
            "position": "311"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "E",
            "position": "104"
          },
          "Description in input context": "p.G104E (SNCA mutation causing alpha-synuclein aggregation)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005031"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing LRRK2 variants were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181797.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased LRRK2 kinase activity observed in p.G2019S variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 served as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparison between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 kinase activity within 1.5× standard deviation of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LRRK2 kinase activity exceeding 2× standard deviation of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic mice",
        "Description": "Transgenic mice with SNCA p.G104E mutation were analyzed."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.2:c.311G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Excessive alpha-synuclein aggregates detected in substantia nigra."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "Single cohort of transgenic mice analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Sections from three different brain regions analyzed per mouse."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type mouse brain used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Alpha-synuclein staining intensity < 2× wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Alpha-synuclein staining intensity ≥ 3× wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Culture Assay",
      "Material used": {
        "Material Source": "Patient-derived cells",
        "Material Name": "Induced pluripotent stem cells (iPSCs)",
        "Description": "iPSCs from PARK2 p.L176Q mutation carriers were differentiated into dopaminergic neurons."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001108.3:c.527A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced PARK2 protein levels and increased oxidative stress markers."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three iPSC lines from independent patients analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Triplicate measurements per experiment."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type iPSC-derived neurons used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untransfected cells used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Mann-Whitney U test for non-parametric data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "PARK2 protein expression within 1× standard deviation of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "PARK2 protein expression below 0.5× wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}